Purpose | Board Meetings Date | Announcement Date |
---|---|---|
Board Meeting | 19 May 2025 | 13 May 2025 |
Syncom Formulations India Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2025 inter alia to consider and approve a) To consider and approve Standalone and Consolidated Audited Financial Results of the Company for the Quarter and year ended 31st March 2025; b) To take on record the Standalone and Consolidated Audit Report by Auditors for the Audited Financial Results of the Company for the Quarter and year ended 31st March 2025. c) To consider and approve other matter incidental thereto Pursuant to Regulation 33(3)(d) of SEBI (LODR) Regulations, 2015, we are pleased to submit the Standalone & Consolidated Audited Financial Results along with Auditors Report thereon by Statutory Auditors, Statement of Assets and Liabilities and Cash Flow for the quarter/year ended on 31st March, 2025, in PDF Format, which were approved by the Audit Committee and Board of Directors at their meeting held on Monday, 19th May, 2025. (As Per BSE Announcement dated on 19.05.2025) | ||
Board Meeting | 10 Feb 2025 | 10 Feb 2025 |
Consideration and approval of standalone and consolidated unaudited financial results for the quarter and nine months ended 31.12.2024 | ||
Board Meeting | 11 Nov 2024 | 4 Nov 2024 |
SYNCOM FORMULATIONS (INDIA) LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2024 inter alia to consider and approve Pursuant to Regulation 29(1) (a) of SEBI (LODR) Regulations 2015 read with SEBI (PIT) Regulations 2015 as amended from time to time we are pleased to inform that 3/2024-25 Meeting of the Board of Directors of the Company is scheduled to be held on Monday the 11th day of November 2024 at 4:00 P.M. at the Corporate Office situated at 207 Saket Nagar Near Saket Club Indore (M.P.) 452018. Submission of Financials for the Half year ended 30.09.2024 (As Per BSE Announcement dated on 11.11.2024) | ||
Board Meeting | 12 Aug 2024 | 2 Aug 2024 |
SYNCOM FORMULATIONS (INDIA) LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2024 inter alia to consider and approve Pursuant to Regulation 29(1) (a) of SEBI (LODR) Regulations 2015 read with SEBI (PIT) Regulations 2015 as amended from time to time we are pleased to inform that 2/2024-25 Meeting of the Board of Directors of the Company is scheduled to be held on Monday the 12th day of August 2024at 4:00 P.M. at the Corporate Office situated at 207 Saket Nagar Near Saket Club Indore (M.P.) 452018 Submission of Unaudited Standalone and Consolidated financial Results for the quarter ended 30.06.2024 (As Per BSE Announcement Dated on: 12/08/2024) |
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.